A detailed history of Psi Advisors, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Psi Advisors, LLC holds 600 shares of ACAD stock, worth $8,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 600 -0.0%
Holding current value
$8,874
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 19, 2023

SELL
$14.2 - $18.63 $1,420 - $1,863
-100 Reduced 14.29%
600 $0
Q3 2021

Nov 12, 2021

BUY
$15.78 - $24.77 $11,046 - $17,339
700 New
700 $12,000
Q1 2020

May 15, 2020

SELL
$31.65 - $46.87 $26,902 - $39,839
-850 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$36.21 - $51.4 $30,778 - $43,690
850 New
850 $36,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Psi Advisors, LLC Portfolio

Follow Psi Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.